Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) in elder or intensive chemotherapy ineligible patients with newly diagnosed acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Suo X 

PROVIDER: S-EPMC11579393 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature